Aurigene Discovery Technologies Limited
Clinical trials sponsored by Aurigene Discovery Technologies Limited, explained in plain language.
Biotechnology company focused on drug discovery and development.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill AUR107 enters first human tests for tough cancers Results expected Jan 2027 (estimated)
- New pill aims to fight advanced lymphoma when other treatments fail Results expected Jan 2027 (estimated)
- New pill aims to tame advanced lymphomas in early trial Results expected Aug 2027 (estimated)